Phase I study of CPT-11 and etoposide in patients with refractory solid tumors. [electronic resource]
Producer: 19931105Description: 2030-5 p. digitalISSN:- 0732-183X
- Adult
- Aged
- Agranulocytosis -- chemically induced
- Antineoplastic Agents, Phytogenic -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Camptothecin -- administration & dosage
- Drug Administration Schedule
- Etoposide -- administration & dosage
- Female
- Granulocyte Colony-Stimulating Factor -- therapeutic use
- Humans
- Irinotecan
- Male
- Middle Aged
- Neoplasms -- drug therapy
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.